§ 21-28-3.20.1. Authority of practitioner to prescribe, administer, and dispense — Cancer, palliative care and chronic intractable pain. (a) A practitioner, in good faith and in the course of his or her professional practice managing pain associated with a cancer diagnosis, palliative or nursing home care, intractable or chronic intractable pain as provided in § […]
§ 21-28-3.21. Operation of treatment and rehabilitation programs for drug dependent persons. The administering or dispensing directly, but not prescribing, of any controlled substance listed in any schedule to a drug dependent person for the purpose of continuing his or her dependence upon the drugs in the course of conducting an authorized clinical investigation in […]
§ 21-28-3.22. Administration, dispensation or use restricted to scope of employment or duty. A person in charge of a hospital or a laboratory, or in the employ of this state, or of any other state, or of any political subdivision of a state, or a master of a ship or a person in charge of […]
§ 21-28-3.23. Advertising controlled substances. No practitioner, manufacturer, or wholesaler shall solicit by public advertisement or otherwise application to him or her for prescription for, or sales of, controlled substances, or shall publicly advertise any treatment the principal element of which consists in the administering, dispensing, furnishing, giving away, or delivering of a controlled substance, […]
§ 21-28-3.24. Examination before use of controlled substances. No physician, dentist, osteopath, chiropodist, or veterinarian shall administer, dispense, or prescribe any controlled substance in schedules II, III, and IV, except after an original physical examination of the person for whom, or the animal for which the controlled substance is intended. History of Section.P.L. 1974, ch. […]
§ 21-28-3.25. Subpoena powers. The director of health shall have power to administer oaths, summon and examine witnesses, and order the production and examination of books, accounts, papers, records, and documents in any proceedings within the jurisdiction of the department. All subpoenas, and orders for the production of books, accounts, papers, records, and documents shall […]
§ 21-28-3.26. Labeling by manufacturers and wholesalers. Whenever a manufacturer sells a controlled substance in packages designed for sale at retail and whenever a wholesaler sells or distributes a controlled substance in a package prepared by him or her, the manufacturer shall securely affix to each individual package in which that controlled substance is contained […]
§ 21-28-3.27. Labeling by dispensing apothecaries. Whenever an apothecary sells or dispenses any controlled substance on a prescription issued by a practitioner, he or she shall affix to the container in which the controlled substance is sold or dispensed, a label showing his or her own name and address, or the name, and address of […]
§ 21-28-3.28. Security requirements generally. Security requirements for controlled substances shall be the same as those enumerated in federal law; provided, that the director of health may promulgate additional rules and regulations as required to prevent diversion of controlled substances. History of Section.P.L. 1974, ch. 183, § 2.
§ 21-28-3.29. Repealed.
§ 21-28-3.30. Persons exempt from restrictions on possession of controlled substances. The provisions of this chapter restricting the possession and having control of controlled substances shall not apply to: (1) Common carriers or to warehouse operators while engaged in lawfully transporting or storing controlled substances, or to any employee of them acting within the scope […]
§ 21-28-3.31. Use of imitation controlled substance in research — Immunity. No civil or criminal liability shall be imposed by virtue of this chapter on any practitioner, apothecary, or other person registered under this chapter who manufactures, distributes, or possesses an imitation controlled substance for use as a placebo by a registered practitioner in the […]
§ 21-28-3.32. Electronic prescription database. [Effective until January 1, 2023.] (a) The information contained in any prescription-drug-monitoring database maintained by the department of health pursuant to § 21-28-3.18 shall be disclosed only: (1) To a practitioner who certifies that the requested information is for the purpose of evaluating the need for, or providing medical treatment […]
§ 21-28-3.33. Voluntary non-opiate directive form. (a) The department shall establish a voluntary non-opiate directive form. The form shall indicate to all practitioners that an individual shall not be administered or offered a prescription or medication order for an opiate. The form shall be posted on the department’s searchable website. An individual may execute and […]
